X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Shelter Pharma Ltd.
BSE CODE: 543963   |   NSE CODE: NA   |   ISIN CODE : INE013V01011   |   27-Jun-2025 Hrs IST
BSE NSE
Rs. 45.45
1.78 ( 4.08% )
 
Prev Close ( Rs.)
43.67
Open ( Rs.)
44.00
 
High ( Rs.)
46.20
Low ( Rs.)
43.11
 
Volume
174000
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Source DateBoard Meeting DateDetails
24-Jun-2025 26-Jun-2025 Preferential Issue of shares & Inter alia, to consider, evaluate and approve: 1. To consider and approve to raise funds by way of issue of Convertible Equity Warrants convertible into the Equity Shares of face value of Rs. 10/- each of the Company, the proposed Allottees of such Warrants, Number of Warrants, Issue Price and other relevant details relation to Warrants, by way of Preferential Issue and Private Placement in one or more tranches, subject to applicable law and requisite approvals including approval of the Shareholders of the Company, Government / Regulatory / Statutory approvals, as may be applicable. 2. To decide on convening of Extra Ordinary General Meeting to take necessary approvals of the Shareholders for Issue of convertible securities as warrants. 3. To transact any other matter with permission of the Chairperson
16-Jun-2025 18-Jun-2025 Inter-alia, to consider and approve:- 1. re-evaluate the proposal for fund raising through the issue of equity shares of the Company on Rights Basis. 2. To consider raising of funds through issue of Warrants or such other Securities which may or may not be Convertible into Equity Shares of the Company
26-May-2025 29-May-2025 Audited Results
03-Jan-2025 08-Jan-2025 Inter alia, to consider the proposal for fund raising through the issue of equity shares of the Company on Rights Basis to existing equity shareholders of the Company, as may be permitted under applicable law, subject to such regulatory and/or statutory approvals, as may be applicable
24-Oct-2024 30-Oct-2024 Half Yearly Results
04-Sep-2024 07-Sep-2024 Inter alia, to consider and approve:- 1. To consider and approve the Draft Notice for calling 17th Annual General Meeting 2. To Approve the Draft of Directors' Report 3. To consider Recommendation a final dividend @ 3.3% (i.e Rs. 0.33/-) per equity share of Rs. 10/- 4. To consider and approve the increase in the Authorized Share Capital of the Company 5. To consider and approve a change in terms of payment of remuneration to Mr. Mustaqim Nisarahmed Sabugar, Managing Director (Din: 01456841) of the company 6. To consider and approve a change in terms of payment of remuneration of Mr. Shakil Nisarahmed Sabugar, Whole-Time Director (Din: 01474868) of the company
17-May-2024 24-May-2024 Audited Results
02-Nov-2023 10-Nov-2023 Half Yearly Results
Page 1 of 1
PREV || NEXT